Editorial · 13 May 2026
CommentaryPublished 24 Jan 2023
Advances in therapeutic drug monitoring and mycobacterial infections
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tuberculosis (TB) is a main source of irresistible passing. Nontuberculous mycobacteria (NTM) cause a wide assortment of challenging to-treat contaminations in different human hosts. Therapeutic drug monitoring (TDM) stays a standard clinical strategy that utilizes plasma drug focuses to decide portion. The motivation to do this is basic: drug openness (that is, the free medication region under the plasma focus time bend) comparative with the MIC and not the portion as such generally decides the result of the contaminations. TDM gives objective data that clinician can use to settle on informed dosing choices. The typical plasma fixation ranges give sensible direction to starting objective focuses. Clinicians then consolidate focus information with information about the patients, to choose how forceful to with portion.
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Archives of General Internal Medicine.
Editorial · 13 May 2026
Pulmonary function and sleep disorders: An integrated approach
Editorial · 13 May 2026
Cardiac imaging, hemodynamics, and arrhythmia management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of General Internal Medicine
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Robert Woods”
